These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


218 related items for PubMed ID: 25939307

  • 1. Angiotensin-converting enzyme inhibition prevents myocardial infarction-induced increase in renal cortical cGMP and cAMP phosphodiesterase activities.
    Clauss F, Charloux A, Piquard F, Doutreleau S, Talha S, Zoll J, Lugnier C, Geny B.
    Fundam Clin Pharmacol; 2015 Aug; 29(4):352-61. PubMed ID: 25939307
    [Abstract] [Full Text] [Related]

  • 2. Increased cGMP phosphodiesterase activity mediates renal resistance to ANP in rats with bile duct ligation.
    Ni XP, Safai M, Gardner DG, Humphreys MH.
    Kidney Int; 2001 Apr; 59(4):1264-73. PubMed ID: 11260387
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Inhibition of both angiotensin-converting enzyme and neutral endopeptidase by S21402 (RB105) in rats with experimental myocardial infarction.
    Gonzalez W, Beslot F, Laboulandine I, Fournié-Zaluski MC, Roques BP, Michel JB.
    J Pharmacol Exp Ther; 1996 Aug; 278(2):573-81. PubMed ID: 8768706
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Role of cyclic AMP- and cyclic GMP-phosphodiesterases in the control of cyclic nucleotide levels and smooth muscle tone in rat isolated aorta. A study with selective inhibitors.
    Schoeffter P, Lugnier C, Demesy-Waeldele F, Stoclet JC.
    Biochem Pharmacol; 1987 Nov 15; 36(22):3965-72. PubMed ID: 2825708
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Characterization and selective inhibition of cyclic nucleotide phosphodiesterase isozymes in canine tracheal smooth muscle.
    Torphy TJ, Cieslinski LB.
    Mol Pharmacol; 1990 Feb 15; 37(2):206-14. PubMed ID: 2154670
    [Abstract] [Full Text] [Related]

  • 10. Profiling of cAMP and cGMP phosphodiesterases in isolated ventricular cardiomyocytes from human hearts: comparison with rat and guinea pig.
    Johnson WB, Katugampola S, Able S, Napier C, Harding SE.
    Life Sci; 2012 Feb 27; 90(9-10):328-36. PubMed ID: 22261303
    [Abstract] [Full Text] [Related]

  • 11. Blunted cGMP response to agonists and enhanced glomerular cyclic 3',5'-nucleotide phosphodiesterase activities in experimental congestive heart failure.
    Supaporn T, Sandberg SM, Borgeson DD, Heublein DM, Luchner A, Wei CM, Dousa TP, Burnett JC.
    Kidney Int; 1996 Nov 27; 50(5):1718-25. PubMed ID: 8914042
    [Abstract] [Full Text] [Related]

  • 12. Cyclic nucleotide phosphodiesterases in glomeruli of rat renal cortex.
    Torres VE, Hui YS, Shah SV, Northrup TE, Dousa TP.
    Kidney Int; 1978 Nov 27; 14(5):444-51. PubMed ID: 220459
    [Abstract] [Full Text] [Related]

  • 13. [Effect of several hormones on cyclic 3',5'-nucleotide phosphodiesterase in rat kidneys].
    Iwase K.
    Nihon Naibunpi Gakkai Zasshi; 1983 Oct 20; 59(10):1678-91. PubMed ID: 6319206
    [Abstract] [Full Text] [Related]

  • 14. Role of cyclic nucleotide phosphodiesterase isozymes in intact canine trachealis.
    Torphy TJ, Zhou HL, Burman M, Huang LB.
    Mol Pharmacol; 1991 Mar 20; 39(3):376-84. PubMed ID: 1848659
    [Abstract] [Full Text] [Related]

  • 15. Distinct profiles of phosphodiesterase isozymes in cultured cells derived from nonpigmented and pigmented ocular ciliary epithelium.
    Bode DC, Hamel LT, Wax MB.
    J Pharmacol Exp Ther; 1993 Dec 20; 267(3):1286-91. PubMed ID: 8263791
    [Abstract] [Full Text] [Related]

  • 16. Cyclic 3',5'-adenosine monophosphate phosphodiesterase (cAMP PDE) and cyclic 3',5'-guanosine monophosphate phosphodiesterase (cGMP PDE) in microvessels isolated from bovine cortex.
    Stefanovich V.
    Neurochem Res; 1979 Dec 20; 4(6):681-7. PubMed ID: 232543
    [Abstract] [Full Text] [Related]

  • 17. Porcine detrusor cyclic nucleotide phosphodiesterase isoenzymes: characterization and functional effects of various phosphodiesterase inhibitors in vitro.
    Truss MC, Uckert S, Stief CG, Schulz-Knappe P, Hess R, Forssmann WG, Jonas U.
    Urology; 1995 May 20; 45(5):893-901. PubMed ID: 7747383
    [Abstract] [Full Text] [Related]

  • 18. Phosphodiesterase inhibitors correct resistance to natriuretic peptides in rats with Heymann Nephritis.
    Valentin JP, Ying WZ, Sechi LA, Ling KT, Qiu C, Couser WG, Humphreys MH.
    J Am Soc Nephrol; 1996 Apr 20; 7(4):582-93. PubMed ID: 8724892
    [Abstract] [Full Text] [Related]

  • 19. Role of cyclic nucleotide phosphodiesterases in ischemic preconditioning.
    Lochner A, Genade S, Tromp E, Opie L, Moolman J, Thomas S, Podzuweit T.
    Mol Cell Biochem; 1998 Sep 20; 186(1-2):169-75. PubMed ID: 9774198
    [Abstract] [Full Text] [Related]

  • 20. Specific effects of n-3 fatty acids and 8-bromo-cGMP on the cyclic nucleotide phosphodiesterase activity in neonatal rat cardiac myocytes.
    Picq M, Dubois M, Grynberg A, Lagarde M, Prigent AF.
    J Mol Cell Cardiol; 1996 Oct 20; 28(10):2151-61. PubMed ID: 8930810
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.